These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19706149)

  • 41. Withdrawal of corticosteroids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: a proposed method.
    Murphy SJ; Wang L; Anderson LA; Steinlauf A; Present DH; Mechanick JI
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1078-86. PubMed ID: 19735230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines.
    Wilckens V; Kannengiesser K; Hoxhold K; Frenkel C; Kucharzik T; Maaser C
    Scand J Gastroenterol; 2011 Jul; 46(7-8):855-61. PubMed ID: 21506630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.
    Sturm A; Maaser C; Mendall M; Karagiannis D; Karatzas P; Ipenburg N; Sebastian S; Rizzello F; Limdi J; Katsanos K; Schmidt C; Jeuring S; Colombo F; Gionchetti P
    J Crohns Colitis; 2017 Mar; 11(3):263-273. PubMed ID: 27797918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
    Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
    J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for depression in the elderly inflammatory bowel disease population.
    Long MD; Kappelman MD; Martin CF; Chen W; Anton K; Sandler RS
    J Crohns Colitis; 2014 Feb; 8(2):113-9. PubMed ID: 23932782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perceptions of medication safety among patients with inflammatory bowel disease.
    Cullen G; Donnellan F; Long S; Forry M; Murray FE
    Scand J Gastroenterol; 2010 Sep; 45(9):1076-83. PubMed ID: 20459367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
    Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
    Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
    Kluthe C; Tsui J; Spady D; Carroll M; Wine E; Huynh HQ
    Can J Gastroenterol Hepatol; 2018; 2018():4687041. PubMed ID: 29682493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.
    Kane S; Becker B; Harmsen WS; Kurian A; Morisky DE; Zinsmeister AR
    Am J Gastroenterol; 2012 Feb; 107(2):154-60. PubMed ID: 22306937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.
    Guilcher K; Fournier N; Schoepfer A; Schibli S; Spalinger J; Braegger C; Nydegger A;
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1159-1167. PubMed ID: 29985208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delivering optimal care for inflammatory bowel disease patients in Scotland in 2014.
    Gaya DR
    Scott Med J; 2014 May; 59(2):130-5. PubMed ID: 24728818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.
    Nahon S; Lahmek P; Saas C; Durance C; Olympie A; Lesgourgues B; Gendre JP
    Inflamm Bowel Dis; 2011 Jun; 17(6):1270-6. PubMed ID: 21560190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying predictors of low adherence in patients with inflammatory bowel disease.
    Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study.
    Raknes G; Simonsen P; Småbrekke L
    J Crohns Colitis; 2018 May; 12(6):677-686. PubMed ID: 29385430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
    Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
    Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis.
    Amiesimaka OI; Allemann SS; Braund R; Schultz M; Aluzaite K
    Br J Clin Pharmacol; 2024 Aug; 90(8):1911-1920. PubMed ID: 38689379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors that modify therapy adherence in patients with inflammatory bowel disease.
    Bermejo F; López-San Román A; Algaba A; Guerra I; Valer P; García-Garzón S; Piqueras B; Villa C; Bermejo A; Rodríguez-Agulló JL
    J Crohns Colitis; 2010 Oct; 4(4):422-6. PubMed ID: 21122538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.
    Almakadma AH; De Vol A; Alabdaljabar MS; Aldosari S; Muhsen I; AlFreihi O; Kurdi A; Almadi M; Alsohaibani F
    Saudi J Gastroenterol; 2023; 29(4):233-239. PubMed ID: 37282444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts.
    Kane SV; Robinson A
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1051-8. PubMed ID: 20815833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.
    Horne R; Parham R; Driscoll R; Robinson A
    Inflamm Bowel Dis; 2009 Jun; 15(6):837-44. PubMed ID: 19107771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.